Announcement
23 Mar 2020
On 23 March 2020, the Canadian government allocated CAD792 million for the development and production of medical countermeasures to COVID-19.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
23 Mar 2020
Revocation date:
No revocation date
Updated: 23 Mar 2020
State loan
In force
On 23 March 2020, the government of Canada announced a new COVID-19 stream under the Strategic Innovation Fund (SIF) to support the research and development projects aimed at providing medical coun...
Sign in to see more
Related State Acts
18 May 2021
Canada: Government announces funding for a Canadian biomanufacturing company
31 Mar 2021
Canada: Sanofi makes a CAD 925 million investment in Canada’s biomanufacturing sector with government support
16 Mar 2021
Canada: Novocol Pharma secures funding from the Canadian government
16 Mar 2021
Canada: Government provides funding to a Canadian biotechnology company through Phase II clinical trials of a therapeutic candidate against COVID-19
16 Mar 2021
Canada: KABS Laboratories secure CAD 52.2 million from the Strategic Innovation Fund
02 Feb 2021
Canada: Government provided funding for the advancement of monoclonal antibody therapy for acute respiratory distress syndrome (COVID-19)
02 Feb 2021
Canada: Government provides funding for the production of ribonucleic acid vaccines and future genetic medicines in Canada
23 Oct 2020
Canada: Medicago Inc. secures CAD 173 million from the government for the development of Coronavirus Virus-Like Particle (VLP) vaccine
22 Oct 2020
Canada: Precision NanoSystems secures funding from the government to develop a COVID-19 mRNA vaccine
05 Aug 2020
Canada: Canadian governments supports the clinical trials of Variation Biotechnologies’ COVID-19 vaccine candidate
03 May 2020
Canada: Government invests in antibody discovery technology to fight against COVID-19
Threads
See all
This state act is not part of any Thread yet.